LivaNova · 1 day ago
Manufacturing Engineer
Houston, TX
Full-time
Onsite
Entry, Mid Level
$70K/yr - $85K/yrLivaNova is a global medtech company dedicated to changing lives through innovative healthcare solutions. The Manufacturing Engineer will provide technical support for manufacturing processes, recommend equipment modifications, and ensure production efficiency while mentoring technicians and supporting operational objectives.
Health CareMedical DeviceNeuroscience
Responsibilities
Daily production support
Defect dispositions and non-conformance management and reporting
Manufacturing engineering representation at daily gemba boards
Supports achieving SPQDIP targets
Ensures equipment readiness and coordinates maintenance, calibration and repair
Continuous improvement identification and implementation to reduce waste
Process development and validation
Supports a safe work environment in production
Qualification
Required
Education: Bachelor of Science in Mechanical Engineering, Electrical Engineering, Biomedical Engineering, Manufacturing or Industrial Engineering
Solid modeling experience
Previous manufacturing experience
Previous medical device experience
Preferred
Lean certifications
Benefits
Health benefits – Medical, Dental, Vision
Personal and Vacation Time
Retirement & Savings Plan (401K)
Employee Stock Purchase Plan
Training & Education Assistance
Bonus Referral Program
Service Awards
Employee Recognition Program
Flexible Work Schedules
Company
LivaNova
LivaNova is a medical technology company that specializes in advanced cardiac surgery, neuromodulation, and circulatory support solutions.
Founded in 1987
1001-5000 employees
H1B Sponsorship
LivaNova has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (15)
2024 (7)
2023 (6)
2022 (7)
2021 (9)
2020 (7)
Funding
Current Stage
Public CompanyTotal Funding
$300M2024-03-05Post Ipo Debt· $300M
2015-10-19IPO
Leadership Team
Vladimir Makatsaria
Chief Executive Officer
Alex Shvartsburg
Chief Financial Officer
Recent News
2025-12-24
MarketScreener
2025-12-02
Company data provided by crunchbase